Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Times Interest Earned (2021 - 2026)

Bicycle Therapeutics (BCYC) has disclosed Times Interest Earned for 6 consecutive years, with -$1364.2 as the latest value for Q1 2026.

  • For Q1 2026, Times Interest Earned rose 0.9% year-over-year to -$1364.2; the TTM value through Mar 2026 reached -$1193.8, down 361.45%, while the annual FY2025 figure was -$1199.3, 888.63% down from the prior year.
  • Times Interest Earned hit -$1364.2 in Q1 2026 for Bicycle Therapeutics, down from -$433.47 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$30.92 in Q2 2022 and bottomed at -$1934.7 in Q3 2024.
  • Average Times Interest Earned over 5 years is -$586.56, with a median of -$62.4 recorded in 2023.
  • On a YoY basis, Times Interest Earned climbed as much as 66.69% in 2025 and fell as far as 3463.33% in 2025.
  • Bicycle Therapeutics' Times Interest Earned stood at -$39.0 in 2022, then tumbled by 69.61% to -$66.14 in 2023, then plummeted by 1867.35% to -$1301.2 in 2024, then skyrocketed by 66.69% to -$433.47 in 2025, then crashed by 214.72% to -$1364.2 in 2026.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at -$1364.2, -$433.47, and -$1489.8 for Q1 2026, Q4 2025, and Q3 2025 respectively.